but in the presence of heart failure the NT-proBNP is approximately four times higher than the corresponding BNP level, thus reducing the likelihood of a result in the ambiguous range (i.e. BNP ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Shares of BNP Paribas surged after the French bank posted strong fourth-quarter results, with net income up 15.7% to €2.32bn ...

BNP Paribas SA provides various banking and financial products and services in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates through three divisions: Corporate ...

but in the presence of heart failure the NT-proBNP is approximately four times higher than the corresponding BNP level, thus reducing the likelihood of a result in the ambiguous range; for example ...

A natriuretic-peptide-guided approach to the management of HF was first tested in a pilot study of 69 patients in Christchurch, New Zealand by Troughton and colleagues. [41] In this study ...